EUVIMEDEUVIMED entdecken
Crossref

Relapse and New‐Onset of Autoimmune or Inflammatory Diseases Following Vaccination With SPIKEVAX: Pharmacovigilance Overview From the French Spontaneous Reported System

Lucie Vettoretti iD, Célia Bouaskeur, Nadine Magy-Bertrand, Sophie Gautier, Marie Blanche Valnet Rabier

Fundamental & Clinical Pharmacology · 2025

DOI: 10.1111/fcp.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2025. Verfasst von Lucie Vettoretti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Regional Centre of Pharmacovigilance, Department of Pharmacology, Besançon University Hospital, Besançon, France. Hauptthemen laut MEDLINE: Autoimmune Diseases, 2019-nCoV Vaccine mRNA-1273, Inflammation, COVID-19 Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID‐19 vaccination raises questions in patients with autoimmune or inflammatory diseases (AIID), not included in clinical trials. Concern exists about the risk of activating the immune system or worsening the AIID. However, cases of AIID flare‐ups or new‐onset reported in literature are limited and do not allow conclusions to be drawn on the potential effect of vaccination.

Objective

To explore the clinical features of AIID that occurred after vaccination.

Methods

We performed a retrospective analysis of adverse event following immunization (AEFI) reported in the French National Pharmacovigilance Database (BNPV) following vaccination with SPIKEVAX (mRNA‐1273/Moderna), regardless of the dose received, between Jan 31, 2021 and Jan 31, 2022.

Results

Among the 20 169 AEFI cases recorded in BNPV, 2594 cases identified with Standardized MedDRA Queries “Immune/Mediated/Autoimmune Conditions” were analyzed to select cases of interest. After review by two experts, 368 cases of AIID were finally retained for analysis [age 54 (42–69); female 234 (63.6%); onset median time 4 days (from < 24 h to 179d); serious cases 226 (61.4%)] and divided into two groups: AIID flare‐ups ( n = 174) and AIID new‐onset ( n = 194). SOCs “Musculoskeletal and connective tissue disorders” and “Nervous system disorders” recorded the most of AIID cases whatever flare‐up or new‐onset. Cases reported are mainly ankylosing spondylitis ( n = 20), rheumatoid arthritis ( n = 17), multiple sclerosis ( n = 19) for flare‐ups and Guillain‐Barre syndrome ( n = 27) for new‐onset.

Conclusion

No safety concerns related to AIID following vaccination with SPIKEVAX were found after the reviewing of 368 French cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune Diseases2019-nCoV Vaccine mRNA-1273InflammationCOVID-19 VaccinesCOVID-19HumansPharmacovigilanceFemaleMiddle AgedFranceMaleRetrospective StudiesAdultAgedRecurrenceAdverse Drug Reaction Reporting SystemsVaccinationDatabases, Factual

Stichwörter der Autor:innen

autoimmune diseasemRNA COVID‐19 vaccinenew‐onsetrelapse

Substanzen

2019-nCoV Vaccine mRNA-1273COVID-19 Vaccines

Autor:innen und Institutionen

  • Regional Centre of Pharmacovigilance, Department of Pharmacology, Besançon University Hospital, Besançon, France.
  • Department of Internal Medicine, Besançon University Hospital, Besançon, France.
  • Centre of Pharmacovigilance, Department of Clinical Pharmacology, Lille University, Lille University Hospital, Lille, France.
  • French Network of Regional Pharmacovigilance Centres, Paris, France.

ORCID-Profile: Lucie Vettoretti

Zitieren

APA

Vettoretti, L., Bouaskeur, C., Magy-Bertrand, N., Gautier, S., & Rabier, M. B. V. (2025). Relapse and New‐Onset of Autoimmune or Inflammatory Diseases Following Vaccination With SPIKEVAX: Pharmacovigilance Overview From the French Spontaneous Reported System. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70027

Vancouver

Vettoretti L, Bouaskeur C, Magy-Bertrand N, Gautier S, Rabier MBV. Relapse and New‐Onset of Autoimmune or Inflammatory Diseases Following Vaccination With SPIKEVAX: Pharmacovigilance Overview From the French Spontaneous Reported System. Fundamental & Clinical Pharmacology. 2025. doi:10.1111/fcp.70027

BibTeX
@article{Vettoretti2025,
  author = {Vettoretti, Lucie and Bouaskeur, Célia and Magy-Bertrand, Nadine and Gautier, Sophie and Rabier, Marie Blanche Valnet},
  title = {Relapse and New‐Onset of Autoimmune or Inflammatory Diseases Following Vaccination With SPIKEVAX: Pharmacovigilance Overview From the French Spontaneous Reported System},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2025},
  doi = {10.1111/fcp.70027}
}
Kostenlos starten →